| abstract |
Compounds and compositions are disclosed in which a NAMPT drug unit is linked to a targeting ligand unit by a unit from which a NAMPT inhibitor or derivative compound is released at the target site of action. Methods for treating diseases characterized by the target abnormal cells, such as cancer or an autoimmune disease, are also described through the use of the compounds and compositions of the invention. |